Cellular and gene therapy fields are currently on track for, if not already experiencing, a serious capacity crunch.
Ronald Rader
Advertisement
Ronald A. Rader is senior director, Technical Research, at BioPlan Associates.
Articles by Ronald Rader
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
Advertisement
Latest Updated Articles
Cellular and Gene Therapies Face a Manufacturing Capacity CrunchPublished: October 2nd 2020 | Updated:
Bioprocessing Advances in Vaccine ManufacturePublished: September 4th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AAPS PharmSci 360 2025: The Role of LC–MS in Bioanalysis
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
4
PharmTech Weekly News Roundup – Week of November 3, 2025
5
